cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.7672
-0.0431 (-5.32%)
May 15, 2026, 4:00 PM EDT - Market closed
cbdMD Revenue
cbdMD had revenue of $5.64M in the quarter ending March 31, 2026, with 18.75% growth. This brings the company's revenue in the last twelve months to $19.98M, up 2.00% year-over-year. In the fiscal year ending September 30, 2025, cbdMD had annual revenue of $19.19M, down -1.50%.
Revenue (ttm)
$19.98M
Revenue Growth
+2.00%
P/S Ratio
0.40
Revenue / Employee
$475,822
Employees
42
Market Cap
8.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 19.19M | -291.70K | -1.50% |
| Sep 30, 2024 | 19.48M | -4.67M | -19.35% |
| Sep 30, 2023 | 24.16M | -11.25M | -31.77% |
| Sep 30, 2022 | 35.40M | -9.08M | -20.41% |
| Sep 30, 2021 | 44.48M | 2.60M | 6.20% |
| Sep 30, 2020 | 41.88M | 18.23M | 77.09% |
| Sep 30, 2019 | 23.65M | 23.19M | 5,051.83% |
| Sep 30, 2018 | 459.09K | -4.02M | -89.74% |
| Sep 30, 2017 | 4.47M | 2.44M | 120.27% |
| Sep 30, 2016 | 2.03M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aytu BioPharma | 62.64M |
| Biofrontera | 41.71M |
| Sonoma Pharmaceuticals | 17.72M |
| TherapeuticsMD | 3.35M |
| China SXT Pharmaceuticals | 1.54M |
| Akanda | 836.66K |
| RedHill Biopharma | 286.00K |
| Gelteq | 270.85K |
YCBD News
- 2 days ago - cbdMD Earnings Call Transcript: Q2 2026 - Transcripts
- 2 days ago - cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum - PRNewsWire
- 4 days ago - cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results - PRNewsWire
- 6 weeks ago - cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare - PRNewsWire
- 6 weeks ago - cbdMD Transcript: AGM 2026 - Transcripts
- 3 months ago - cbdMD Earnings Call Transcript: Q1 2026 - Transcripts
- 3 months ago - cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 - PRNewsWire
- 3 months ago - cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results - PRNewsWire